Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is assess safety, safest dose, and effectiveness of venetoclax in combination with dexamethasone in participants with t(11;14) positive relapsed (comes back) or refractory (did not get better) light chain amyloidosis.
Epistemonikos ID: 09609ea6ac1f8835d3b72b2a0df119ee89c33d06
First added on: May 13, 2024